Regarding reports from Uzbekistan concerning contaminated cough syrup made by Indian company Marion Biotech, Noida, Uttar Pradesh, the @CDSCO_INDIA_INF is in regular contact with the national drug regulator of Uzbekistan since 27th December. (1/3)

— Dr. Mansukh Mandaviya (@mansukhmandviya) December 29, 2022

“Marion Biotech is a licensed manufacturer and has a licence by the Drug Controller General of Uttar Pradesh to manufacture ‘Doc-1 Max’ syrups and tablets for export purpose,” the health ministry said in a statement.

The Drug Controller General of India (DCGI) had earlier this month told the World Health Organisation (WHO) that it had immaturely linked the deaths of children in the Gambia to four cough syrups made in India, which adversely affected the image of the country’s pharmaceutical products worldwide.

In a letter to Dr Rogerio Gasper, Director (Regulation and Pre-Qualifications) at WHO, Dr V G Somani, Drug Controller General of India, had said that in the wake of the deaths, it was hastily linked to the cough syrup manufactured in India by the global health body in October, which led to an international discourse targeting the quality of Indian pharmaceutical products.

The Drug Controller General of India had said that India is committed to strict monitoring and inspection to ensure that the highest standards of quality are maintained in the manufacture of medicines and cosmetics.

(with input from news agency language)

Read Also: